Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$165.67 - $199.94 $10.6 Million - $12.8 Million
-64,088 Reduced 98.16%
1,200 $203,000
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $842,309 - $1.11 Million
5,562 Added 9.31%
65,288 $12.9 Million
Q3 2023

Nov 22, 2023

BUY
$167.14 - $192.77 $782,048 - $901,970
4,679 Added 8.5%
59,726 $10.4 Million
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $7.4 Million - $8.57 Million
45,997 Added 508.25%
55,047 $9.48 Million
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $298,234 - $358,791
2,050 Added 29.29%
9,050 $1.51 Million
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $976,786 - $1.2 Million
-6,587 Reduced 48.48%
7,000 $1.04 Million
Q2 2022

Aug 16, 2022

SELL
$155.97 - $200.09 $101,380 - $130,058
-650 Reduced 4.57%
13,587 $2.34 Million
Q1 2022

May 18, 2022

SELL
$181.39 - $234.03 $1.6 Million - $2.06 Million
-8,822 Reduced 38.26%
14,237 $2.69 Million
Q4 2021

Feb 15, 2022

BUY
$193.69 - $247.03 $813,498 - $1.04 Million
4,200 Added 22.27%
23,059 $5.63 Million
Q3 2021

Nov 15, 2021

SELL
$189.29 - $209.69 $5.15 Million - $5.71 Million
-27,220 Reduced 59.07%
18,859 $3.66 Million
Q2 2021

Aug 10, 2021

BUY
$155.9 - $187.99 $1.81 Million - $2.19 Million
11,624 Added 33.74%
46,079 $8.59 Million
Q1 2021

Sep 15, 2021

BUY
$144.0 - $169.39 $481,680 - $566,609
3,345 Added 10.75%
34,455 $5.43 Million
Q4 2020

Feb 16, 2021

SELL
$157.07 - $174.35 $6,282 - $6,974
-40 Reduced 0.13%
31,110 $5.15 Million
Q3 2020

Nov 16, 2020

SELL
$137.1 - $165.37 $102,276 - $123,366
-746 Reduced 2.34%
31,150 $5.15 Million
Q2 2020

Aug 14, 2020

BUY
$111.92 - $142.53 $3.57 Million - $4.55 Million
31,896 New
31,896 $4.37 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Connors Investor Services Inc Portfolio

Follow Connors Investor Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connors Investor Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Connors Investor Services Inc with notifications on news.